Shinhung Co., Ltd (KRX:004080)
14,000
-60 (-0.43%)
At close: Sep 11, 2026
Shinhung Revenue
Shinhung had revenue of 26.28B KRW in the quarter ending June 30, 2026, with 7.09% growth. This brings the company's revenue in the last twelve months to 105.89B, up 7.30% year-over-year. In the year 2025, Shinhung had annual revenue of 102.61B with 0.84% growth.
Revenue (ttm)
105.89B
Revenue Growth
+7.30%
P/S Ratio
1.21
Revenue / Employee
n/a
Employees
n/a
Market Cap
128.63B
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 102.61B | 851.32M | 0.84% |
| Dec 31, 2024 | 101.76B | -10.69B | -9.50% |
| Dec 31, 2023 | 112.44B | -5.73B | -4.85% |
| Dec 31, 2022 | 118.18B | -8.68B | -6.84% |
| Dec 31, 2021 | 126.85B | 10.20B | 8.74% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Vieworks | 244.28B |
| Boditech Med | 174.78B |
| DRTECH | 126.23B |
| Dongbang Medical | 125.12B |
| Ray Co., Ltd. | 119.17B |
| Bio Plus | 99.15B |
| Osang Healthcare Co.,Ltd | 96.48B |
| T&R Biofab | 32.73B |